Howard Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Howard Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Buy	36,586 +272	+0.7%	+$15.9K	0.04%	117
2025 Q4	$1.96M	Buy	36,314 +10,800	+42%	+$520K	0.03%	166
2025 Q3	$1.15M	Buy	25,514 +2,299	+10%	+$107K	0.02%	211
2025 Q2	$1.07M	Buy	23,215 +4,585	+25%	+$225K	0.02%	212
2025 Q1	$1.14M	Sell	18,630 -1,319	-7%	-$76.9K	0.03%	181
2024 Q4	$1.13M	Buy	19,949 +6,416	+47%	+$358K	0.02%	201
2024 Q3	$700K	Buy	+13,533	New	+$635K	0.01%	244
2020 Q3	–	Sell	-8,671	Closed	-$522K	–	53
2020 Q2	$522K	Buy	+8,671	New	+$519K	0.15%	34

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Capital Management's BMY Position: Q1 2026 in Review

Howard Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.75% in Q1 2026, buying an estimated $15.9K and bringing the position to 36,586 shares worth $2.22M. The position accounts for 0.04% of the portfolio, ranked #117.

Howard Capital Management first reported a position in BMY in Q2 2020 and has held it in 8 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Howard Capital Management held 36,586 shares of Bristol-Myers Squibb worth $2.22M as of Q1 2026.
Howard Capital Management bought 272 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.9K.
Bristol-Myers Squibb made up 0.04% of Howard Capital Management's portfolio in Q1 2026, its #117 holding.
Howard Capital Management first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 8 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.